Y. Zhao, X. Liu, L. Wang, X. Pan, F. Pan, and Q. Ke, “MiR-302 targets PAK5 and prevents the transition from chronic hepatitis B to liver cirrhosis”, J Pak Med Assoc, vol. 74, no. 12, pp. 2114–2121, Nov. 2024.